{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:33:16Z","timestamp":1789155196380,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008777","name":"Fundaci\u00f3n Bunge y Born","doi-asserted-by":"publisher","award":["4\u00b0 Concurso de Subsidios Bunge y Born 2015\/16 para la Investigaci\u00f3n de Enfermedades Infeccionsas"],"award-info":[{"award-number":["4\u00b0 Concurso de Subsidios Bunge y Born 2015\/16 para la Investigaci\u00f3n de Enfermedades Infeccionsas"]}],"id":[{"id":"10.13039\/501100008777","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secretar\u00eda de Ciencia y Tecnolog\u00eda \u2013 Universidad Nacional de C\u00f3rdoba","award":["SeCyT 2014\/2015, Res. 203\/2014"],"award-info":[{"award-number":["SeCyT 2014\/2015, Res. 203\/2014"]}]},{"name":"Secretar\u00eda de Ciencia y Tecnolog\u00eda \u2013 Universidad Nacional de C\u00f3rdoba","award":["SeCyT 2016\/2017, Res. 313\/2016"],"award-info":[{"award-number":["SeCyT 2016\/2017, Res. 313\/2016"]}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2012-2014"],"award-info":[{"award-number":["PIP 2012-2014"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13346-021-00896-8","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T16:03:28Z","timestamp":1611763408000},"page":"180-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis"],"prefix":"10.1007","volume":"12","author":[{"given":"Ma. Florencia","family":"Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadina A.","family":"Usseglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Estefan\u00eda","family":"Bracamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Laura","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Eugenia","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Diego","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-4226","authenticated-orcid":false,"given":"Dolores C.","family":"Carrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"896_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1751-1097.1977.tb07416.x","volume":"25","author":"M Sun","year":"1977","unstructured":"Sun M, Song PS. Solvent effects on the fluorescent states of indole derivatives-dipole moments. Photochem Photobiol. 1977;25:3\u20139.","journal-title":"Photochem Photobiol"},{"key":"896_CR2","doi-asserted-by":"crossref","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. United States; 2012;7:e35671.","DOI":"10.1371\/journal.pone.0035671"},{"key":"896_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.actatropica.2003.11.011","volume":"90","author":"CCG Oliveira","year":"2004","unstructured":"Oliveira CCG, Lacerda HG, Martins DRM, Barbosa JDA, Monteiro GR, Queiroz JW, et al. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop. 2004;90:155\u201362.","journal-title":"Acta Trop"},{"key":"896_CR4","first-page":"15","volume":"19","author":"HL Pizzi","year":"2015","unstructured":"Pizzi HL, T\u00f3mas AF, Ferrero MR, Pizzi (h) HL, Fern\u00e1ndez GL, Furey F, et al. El inexorable avance de la Leishmaniasis: comunicaci\u00f3n del primer caso aut\u00f3ctono de la Provincia de C\u00f3rdoba. Rev Salud P\u00fablica. 2015;19:15\u201323.","journal-title":"Rev Salud P\u00fablica."},{"key":"896_CR5","doi-asserted-by":"crossref","unstructured":"Desjeux P, Alvar J. Leishmania\/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. England; 2003;97 Suppl 1:3\u201315.","DOI":"10.1179\/000349803225002499"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis England. 2004;27:305\u201318.","journal-title":"Comp Immunol Microbiol Infect Dis England"},{"key":"896_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12889-018-5060-2","volume":"18","author":"JA Cardona-Arias","year":"2018","unstructured":"Cardona-Arias JA, L\u00f3pez-Carvajal L, Tamayo-Plata MP, V\u00e9lez ID. Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia. BMC Public Health. 2018;18:185.","journal-title":"BMC Public Health"},{"key":"896_CR8","doi-asserted-by":"crossref","unstructured":"Eid Rodr\u00edguez D, San Sebastian M, Pulkki-Br\u00e4nnstr\u00f6m A-M. \u201cCheaper and better\u201d: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia. PLoS Negl Trop Dis. Public Libr Sci. 2019;13:e0007788\u20138.","DOI":"10.1371\/journal.pntd.0007788"},{"key":"896_CR9","doi-asserted-by":"crossref","unstructured":"Brito NC, Machado de Assis TS, Rabello A, Cota G. Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis. PLoS Negl Trop Dis. Public Libr Sci. 2019;13:e0007856.","DOI":"10.1371\/journal.pntd.0007856"},{"key":"896_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12914-019-0196-4","volume":"19","author":"D Eid","year":"2019","unstructured":"Eid D, San Sebastian M, Hurtig A-K, Goicolea I. Leishmaniasis patients\u2019 pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach. BMC Int Health Hum Rights. 2019;19:12.","journal-title":"BMC Int Health Hum Rights"},{"key":"896_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","volume":"5","author":"P Minodier","year":"2007","unstructured":"Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis Netherlands. 2007;5:150\u20138.","journal-title":"Travel Med Infect Dis Netherlands"},{"key":"896_CR12","unstructured":"Ministerio de Salud y Desarrollo Social P de la NA. Bolet\u00edn Integrado de Vigilancia. 2018."},{"key":"896_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bpobgyn.2012.01.004","volume":"26","author":"JL Adams","year":"2012","unstructured":"Adams JL, Kashuba ADM. Formulation, pharmacokinetics and pharmacodynamics of topical microbicides. Best Pract Res Clin Obstet Gynaecol. 2012;26:451\u201362.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"896_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2230.2000.00664.x","volume":"25","author":"NC Hepburn","year":"2000","unstructured":"Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol Wiley Online Library. 2000;25:363\u201370.","journal-title":"Clin Exp Dermatol Wiley Online Library"},{"key":"896_CR15","doi-asserted-by":"crossref","unstructured":"L\u00f3pez L, V\u00e9lez I, Asela C, Cruz C, Alves F, Robledo S, et al. A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia. PLoS Negl Trop Dis. Public Library of Science; 2018;12:e0006653.","DOI":"10.1371\/journal.pntd.0006653"},{"key":"896_CR16","first-page":"153","volume":"91","author":"RX Armijos","year":"2004","unstructured":"Armijos RX, Weigel MM, Calvopi\u00f1a M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. 2004;91:153\u201360.","journal-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis"},{"key":"896_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","volume":"28","author":"G Faghihi","year":"2003","unstructured":"Faghihi G, Tavakoli-kia R. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clin Exp Dermatol. 2003;28:13\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"896_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/clinids\/20.1.47","volume":"20","author":"H Mejia","year":"1995","unstructured":"Mejia H, Berman J, Soto J, Grogl M, Hernandez N. Successful treatment of New World cutaneous Leishmaniasis with a combination of topical paromomycin\/methylbenzethonium chloride and injectable meglumine antimonate. Clin Infect Dis. 1995;20:47\u201351.","journal-title":"Clin Infect Dis"},{"key":"896_CR19","first-page":"370","volume":"66","author":"I Paola Hernandez","year":"2014","unstructured":"Paola Hernandez I, Escobar Rivero P, Martinetti Montanari JA. Actividad in vitro contra Leishmania y permeaci\u00f3n en piel humana de liposomas ultradeformables de miltefosina TT - In vitro activity against Leishmania and human skin permeation of miltefosine ultradeformable liposomes. Rev Cuba Med Trop. 2014;66:370\u201385.","journal-title":"Rev Cuba Med Trop"},{"key":"896_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/08982104.2012.762519","volume":"23","author":"A Momeni","year":"2013","unstructured":"Momeni A, Rasoolian M, Momeni A, Navaei A, Emami S, Shaker Z, et al. Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis. J Liposome Res England. 2013;23:134\u201344.","journal-title":"J Liposome Res England"},{"key":"896_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1645\/GE-1613.1","volume":"94","author":"DC Ayres","year":"2008","unstructured":"Ayres DC, Pinto LA, Giorgio S. Efficacy of pentavalent antimony, amphotericin B, and Miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions. J Parasitol Am Soc Parasitol. 2008;94:1415\u20137.","journal-title":"J Parasitol Am Soc Parasitol"},{"key":"896_CR22","doi-asserted-by":"crossref","unstructured":"Croft SL, Engel J. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives. Trans R Soc Trop Med Hyg. England; 2006;100 Suppl:S4\u20138.","DOI":"10.1016\/j.trstmh.2006.03.009"},{"key":"896_CR23","doi-asserted-by":"crossref","unstructured":"Marinho FDA, Cristiny K, Oliveira SS De, Oliveira ADSC De, Bellio M, Avila-levy CM, et al. Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes.pdf. 2011;106:507\u20139.","DOI":"10.1590\/S0074-02762011000400021"},{"key":"896_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/jac\/dkh380","volume":"54","author":"RM Santa-Rita","year":"2004","unstructured":"Santa-Rita RM, Henriques-Pons A, Barbosa HS, de Castro SL. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis. J Antimicrob Chemother. 2004;54:704\u201310.","journal-title":"J Antimicrob Chemother"},{"key":"896_CR25","doi-asserted-by":"crossref","unstructured":"Varela-M RE, Villa-Pulgarin JA, Yepes E, Muller I, Modolell M, Munoz DL, et al. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites. PLoS Negl Trop Dis. United States; 2012;6:e1612.","DOI":"10.1371\/journal.pntd.0001612"},{"key":"896_CR26","doi-asserted-by":"crossref","unstructured":"Sunyoto T, Potet J, Boelaert M. Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most. BMJ Glob Heal. England; 2018;3:e000709.","DOI":"10.1136\/bmjgh-2018-000709"},{"key":"896_CR27","unstructured":"Schlossberg D, Samuel R. Miltefosine (Impavido, Miltex). Antibiot manual A Guid to commonly used anti-microbials. 2011;287\u20138."},{"key":"896_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijid.2003.10.006","volume":"8","author":"JA Al-Tawfiq","year":"2004","unstructured":"Al-Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956\u20132002). Int J Infect Dis Canada. 2004;8:244\u201350.","journal-title":"Int J Infect Dis Canada"},{"key":"896_CR29","doi-asserted-by":"crossref","unstructured":"Brandao-Filho SP, Campbell-Lendrum D, Brito ME, Shaw JJ, Davies CR. Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil. Trans R Soc Trop Med Hyg. England; 1999;93:488\u201394.","DOI":"10.1016\/S0035-9203(99)90346-2"},{"key":"896_CR30","doi-asserted-by":"publisher","first-page":"816","DOI":"10.26719\/2003.9.4.816","volume":"9","author":"MR Yaghoobi-Ershadi","year":"2003","unstructured":"Yaghoobi-Ershadi MR, Akhavan AA, Zahraei-Ramazani AV, Abai MR, Ebrahimi B, Vafaei-Nezhad R, et al. Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediterr Health J Egypt. 2003;9:816\u201326.","journal-title":"East Mediterr Health J Egypt"},{"key":"896_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1645\/13-376.1","volume":"100","author":"MF Garc\u00eda Bustos","year":"2014","unstructured":"Garc\u00eda Bustos MF, Barrio A, Prieto GG, de Raspi EM, Cimino RO, Cardozo RM, et al. In vivo antileishmanial efficacy of Miltefosine against Leishmania ( Leishmania ) amazonensis. J Parasitol. 2014;100:840\u20137.","journal-title":"J Parasitol"},{"key":"896_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0035-9203(99)90192-X","volume":"93","author":"R Schmidt-Ott","year":"1999","unstructured":"Schmidt-Ott R, Klenner T, Overath P, Aebischer T. Topical treatment with hexadecylphosphocholine (Miltex\u00ae) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1999;93:85\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"896_CR33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/jphp.12548","volume":"68","author":"K Van Bocxlaer","year":"2016","unstructured":"Van Bocxlaer K, Yardley V, Murdan S, Croft SL. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB\/c mouse model. J Pharm Pharmacol. 2016;68:862\u201372.","journal-title":"J Pharm Pharmacol"},{"key":"896_CR34","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1038\/s41598-018-31693-y","volume":"8","author":"MF Peralta","year":"2018","unstructured":"Peralta MF, Guzm\u00e1n ML, P\u00e9rez AP, Apezteguia GA, F\u00f3rmica ML, Romero EL, et al. Liposomes can both enhance or reduce drugs penetration through the skin. Sci Rep. 2018;8:13253.","journal-title":"Sci Rep"},{"key":"896_CR35","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1517\/17425247.2012.701204","volume":"9","author":"G Carneiro","year":"2012","unstructured":"Carneiro G, Aguiar MG, Fernandes AP, Ferreira LAM. Drug delivery systems for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Deliv. 2012;9:1083\u201397.","journal-title":"Expert Opin Drug Deliv"},{"key":"896_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08982104.2014.950276","volume":"25","author":"TA Ahmed","year":"2015","unstructured":"Ahmed TA. Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization. J Liposome Res England. 2015;25:1\u201310.","journal-title":"J Liposome Res England"},{"key":"896_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2008.08.006","volume":"132","author":"DC Carrer","year":"2008","unstructured":"Carrer DC, Vermehren C, Bagatolli LA. Pig skin structure and transdermal delivery of liposomes: a two photon microscopy study. J Control Release Netherlands. 2008;132:12\u201320.","journal-title":"J Control Release Netherlands"},{"key":"896_CR38","doi-asserted-by":"crossref","unstructured":"Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. Netherlands; 1998;1368:201\u201315.","DOI":"10.1016\/S0005-2736(97)00177-6"},{"key":"896_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1517\/17425247.2011.574610","volume":"8","author":"ML Gonzalez-Rodriguez","year":"2011","unstructured":"Gonzalez-Rodriguez ML, Rabasco AM. Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin Drug Deliv England. 2011;8:857\u201371.","journal-title":"Expert Opin Drug Deliv England"},{"key":"896_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.amjsurg.2006.08.069","volume":"193","author":"B Chiang","year":"2007","unstructured":"Chiang B, Essick E, Ehringer W, Murphree S, Hauck MA, Li M, et al. Enhancing skin wound healing by direct delivery of intracellular adenosine triphosphate. Am J Surg United States. 2007;193:213\u20138.","journal-title":"Am J Surg United States"},{"key":"896_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/jir.2005.25.627","volume":"25","author":"JP Lee","year":"2005","unstructured":"Lee JP, Jalili RB, Tredget EE, Demare JR, Ghahary A. Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res United States. 2005;25:627\u201331.","journal-title":"J Interferon Cytokine Res United States"},{"key":"896_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0009-3084(99)00050-X","volume":"100","author":"H Ichimori","year":"1999","unstructured":"Ichimori H, Hata T, Matsuki H, Kaneshina S. Effect of unsaturated acyl chains on the thermotropic and barotropic phase transition of phospholipid bilayer membranes. Chem Phys Lipids. 1999;100:151\u201364.","journal-title":"Chem Phys Lipids"},{"key":"896_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ddtec.2005.05.003","volume":"2","author":"PL Honeywell-Nguyen","year":"2005","unstructured":"Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol England. 2005;2:67\u201374.","journal-title":"Drug Discov Today Technol England"},{"key":"896_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0005-2736(01)00366-2","volume":"1514","author":"DC Carrer","year":"2001","unstructured":"Carrer DC, Maggio B. Transduction to self-assembly of molecular geometry and local interactions in mixtures of ceramides and ganglioside GM1. Biochim Biophys Acta Netherlands. 2001;1514:87\u201399.","journal-title":"Biochim Biophys Acta Netherlands"},{"key":"896_CR45","unstructured":"Fal\u00fa MA, Garc\u00eda Bustos MF, Parodi Ramoneda CM, Molina de Raspi E, Marino Cardozo R, Cimino R, et al. Susceptibility of different mouse strains to Leishmania amazonensis infection. Dermatol Argent. 2009;15(5):334\u20139."},{"key":"896_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0169-4758(96)40010-2","volume":"13","author":"HC Lima","year":"1997","unstructured":"Lima HC, Bleyenberg JA, Titus RG. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today England. 1997;13:80\u20132.","journal-title":"Parasitol Today England"},{"key":"896_CR47","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1128\/iai.39.3.1087-1094.1983","volume":"39","author":"JO Hill","year":"1983","unstructured":"Hill JO, North RJ, Collins FM. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect Immun United States. 1983;39:1087\u201394.","journal-title":"Infect Immun United States"},{"key":"896_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1128\/AAC.00887-13","volume":"58","author":"AG Peniche","year":"2014","unstructured":"Peniche AG, Osorio Y, Renslo AR, Frantz DE, Melby PC, Travi BL. Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major. Antimicrob Agents Chemother United States. 2014;58:78\u201387.","journal-title":"Antimicrob Agents Chemother United States"},{"key":"896_CR49","first-page":"1240","volume":"209","author":"KP Chang","year":"1980","unstructured":"Chang KP. Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science United States. 1980;209:1240\u20132.","journal-title":"Science United States"},{"key":"896_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","volume":"200","author":"DS Dias","year":"2018","unstructured":"Dias DS, Ribeiro PAF, Martins VT, Lage DP, Costa LE, Chavez-Fumagalli MA, et al. Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis. Transl Res United States. 2018;200:18\u201334.","journal-title":"Transl Res United States"},{"key":"896_CR51","volume-title":"Handbook on Isolation, Characterization and Cryopreservation of Leishmania","author":"D Evans","year":"1989","unstructured":"Evans D. Handbook on Isolation, Characterization and Cryopreservation of Leishmania. Geneva: WHO; 1989."},{"key":"896_CR52","doi-asserted-by":"crossref","unstructured":"Marco JD, Barroso PA, Calvopina M, Kumazawa H, Furuya M, Korenaga M, et al. Species assignation of Leishmania from human and canine American tegumentary leishmaniasis cases by multilocus enzyme electrophoresis in North Argentina. Am J Trop Med Hyg. United States; 2005;72:606\u201311.","DOI":"10.4269\/ajtmh.2005.72.606"},{"key":"896_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1042\/bj0900374","volume":"90","author":"VP Skipski","year":"1964","unstructured":"Skipski VP, Peterson RF, Barclay M. Quantitative analysis of phospholipids by thin-layer chromatography. Biochem J. 1964;90:374\u20138.","journal-title":"Biochem J"},{"key":"896_CR54","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1515\/bchm.1998.379.6.655","volume":"379","author":"TR Klein","year":"1998","unstructured":"Klein TR, Kirsch D, Kaufmann R, Riesner D. Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem Germany. 1998;379:655\u201366.","journal-title":"Biol Chem Germany"},{"key":"896_CR55","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm Poland. 2010;67:217\u201323.","journal-title":"Acta Pol Pharm Poland"},{"key":"896_CR56","doi-asserted-by":"crossref","unstructured":"Arana BA, Mendoza CE, Rizzo NR, Kroeger A. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg. United States; 2001;65:466\u201370.","DOI":"10.4269\/ajtmh.2001.65.466"},{"key":"896_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4269\/ajtmh.1996.54.178","volume":"54","author":"RP Almeida","year":"1996","unstructured":"Almeida RP, Barral-Netto M, De Jesus AMR, De Freitas LAR, Carvalho EM, Barral A. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB\/c mice. Am J Trop Med Hyg. 1996;54:178\u201384.","journal-title":"Am J Trop Med Hyg"},{"key":"896_CR58","unstructured":"Campos BLS. An\u00e1lise de imunogenicidade e prote\u00e7\u00e3o gerada pelos imun\u00f3genos de terceira gera\u00e7\u00e3o pVAX1-FSD e pVAX1-SP contra a leishmaniose tegumentar americana experimental. S\u00e3o Paulo; 2015."},{"key":"896_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmii.2015.05.007","volume":"50","author":"M Rostamian","year":"2017","unstructured":"Rostamian M, Sohrabi S, Kavosifard H, Niknam HM. Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice. J Microbiol Immunol Infect England. 2017;50:160\u20136.","journal-title":"J Microbiol Immunol Infect England"},{"key":"896_CR60","doi-asserted-by":"crossref","unstructured":"Wege AK, Florian C, Ernst W, Zimara N, Schleicher U, Hanses F, et al. Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response. PLoS Negl Trop Dis. Public Library of Science; 2012;6:e1741.","DOI":"10.1371\/journal.pntd.0001741"},{"key":"896_CR61","doi-asserted-by":"crossref","unstructured":"Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effect of the anti-Fas antibody in mice. Nature. Nature Publishing Group; 1993;364:806.","DOI":"10.1038\/364806a0"},{"key":"896_CR62","doi-asserted-by":"crossref","unstructured":"Suckow MA, Danneman P, Brayton C. The laboratory mouse. Press C, editor. 2001.","DOI":"10.1201\/9780849376276"},{"key":"896_CR63","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s13346-018-0523-7","volume":"8","author":"MF Sanchez","year":"2018","unstructured":"Sanchez MF, Breda SA, Soria EA, T\u00e1rtara LI, Manzo RH, Olivera ME. Ciprofloxacin-lidocaine-based hydrogel: development, characterization, and in vivo evaluation in a second-degree burn model. Drug Deliv Transl Res United States. 2018;8:1000\u201313.","journal-title":"Drug Deliv Transl Res United States"},{"key":"896_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","volume":"139","author":"AP Perez","year":"2016","unstructured":"Perez AP, Altube MJ, Schilrreff P, Apezteguia G, Celes FS, Zacchino S, et al. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf B Biointerfaces Netherlands. 2016;139:190\u20138.","journal-title":"Colloids Surf B Biointerfaces Netherlands"},{"key":"896_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1194\/jlr.M600451-JLR200","volume":"48","author":"C Gille","year":"2007","unstructured":"Gille C, Spring B, Bernhard W, Gebhard C, Basile D, Lauber K, et al. Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages. J Lipid Res. 2007;48:307\u201317.","journal-title":"J Lipid Res"},{"key":"896_CR66","doi-asserted-by":"crossref","unstructured":"Grando FCC, Fel\u00edcio CA, Twardowschy A, Paula FM, Batista VG, Fernandes LC, et al. Modulation of peritoneal macrophage activity by the saturation state of the fatty acid moiety of phosphatidylcholine . Brazilian J Med Biol Res scielo ; 2009. p. 599\u2013605.","DOI":"10.1590\/S0100-879X2009005000003"},{"key":"896_CR67","doi-asserted-by":"crossref","unstructured":"Miranda DTSZ, Batista, Vanessa G. Grando, Fernanda C. C. Paula, Fernanda M. Fel\u00edcio, Caroline A. Rubbo, Gabriella F. S. Fernandes LC, Rui C, Nishiyama A. Soy lecithin supplementation alters macrophage phagocytosis and lymphocyte response to concanavalin A: a study in alloxan\u2010induced diabetic rats. Cell Biochem Funct. 2008;26:859\u201365.","DOI":"10.1002\/cbf.1517"},{"key":"896_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/08982100903015025","volume":"20","author":"G Carneiro","year":"2010","unstructured":"Carneiro G, Santos DCM, Oliveira MC, Fernandes AP, Ferreira LS, Ramaldes GA, et al. Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis. J Liposome Res. 2010;20:16\u201323.","journal-title":"J Liposome Res"},{"key":"896_CR69","doi-asserted-by":"crossref","unstructured":"Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst. United States; 1996;13:257\u2013388.","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v13.i3-4.30"},{"key":"896_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejpb.2004.05.010","volume":"58","author":"SI Simoes","year":"2004","unstructured":"Simoes SI, Marques CM, Cruz MEM, Cevc G, Martins MBF. The effect of cholate on solubilisation and permeability of simple and protein-loaded phosphatidylcholine\/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules. Eur J Pharm Biopharm Netherlands. 2004;58:509\u201319.","journal-title":"Eur J Pharm Biopharm Netherlands"},{"key":"896_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-4899-0179-8_53","volume":"416","author":"CC Geilen","year":"1996","unstructured":"Geilen CC, Wieder T, Orfanos CE. Phosphatidylcholine biosynthesis as a target for phospholipid analogues. Adv Exp Med Biol United States. 1996;416:333\u20136.","journal-title":"Adv Exp Med Biol United States"},{"key":"896_CR72","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1128\/AAC.01123-06","volume":"51","author":"M Rakotomanga","year":"2007","unstructured":"Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother United States. 2007;51:1425\u201330.","journal-title":"Antimicrob Agents Chemother United States"},{"key":"896_CR73","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s00216-014-7772-1","volume":"406","author":"GA Canuto","year":"2014","unstructured":"Canuto GA, Castilho-Martins EA, Tavares MF, Rivas L, Barbas C, L\u00f3pez-Gonz\u00e1lvez \u00c1. Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania. Anal Bioanal Chem. 2014;406:3459\u201376.","journal-title":"Anal Bioanal Chem"},{"key":"896_CR74","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","volume":"135","author":"J Mishra","year":"2013","unstructured":"Mishra J, Singh S. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death. Exp Parasitol United States. 2013;135:397\u2013406.","journal-title":"Exp Parasitol United States"},{"key":"896_CR75","doi-asserted-by":"crossref","unstructured":"Pali\u0107 S, Bhairosing P, Beijnen JH, Dorlo TPC. Systematic review of host-mediated activity of miltefosine in Leishmaniasis through immunomodulation. Antimicrob Agents Chemother. American Society for Microbiology; 2019;63:e02507\u201318.","DOI":"10.1128\/AAC.02507-18"},{"key":"896_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamem.2016.10.008","volume":"1859","author":"KS Fernandes","year":"2017","unstructured":"Fernandes KS, de Souza PEN, Dorta ML, Alonso A. The cytotoxic activity of miltefosine against Leishmania and macrophages is associated with dynamic changes in plasma membrane proteins. Biochim Biophys Acta - Biomembr. 2017;1859:1\u20139.","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"896_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.plipres.2012.09.002","volume":"52","author":"A Arouri","year":"2013","unstructured":"Arouri A, Mouritsen OG. Membrane-perturbing effect of fatty acids and lysolipids. Prog Lipid Res England. 2013;52:130\u201340.","journal-title":"Prog Lipid Res England"},{"key":"896_CR78","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","volume":"196","author":"Z Kavian","year":"2019","unstructured":"Kavian Z, Alavizadeh SH, Golmohamadzadeh S, Badiee A, Khamesipour A, Jaafari MR. Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice. Acta Trop Netherlands. 2019;196:142\u20139.","journal-title":"Acta Trop Netherlands"},{"key":"896_CR79","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jac\/dkz049","volume":"74","author":"LF Neira","year":"2019","unstructured":"Neira LF, Mantilla JC, Escobar P. Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis. J Antimicrob Chemother England. 2019;74:1634\u201341.","journal-title":"J Antimicrob Chemother England"},{"key":"896_CR80","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0006-3495(93)81566-2","volume":"64","author":"J Song","year":"1993","unstructured":"Song J, Waugh RE. Bending rigidity of SOPC membranes containing cholesterol. Biophys J United States. 1993;64:1967\u201370.","journal-title":"Biophys J United States"},{"key":"896_CR81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","volume":"247","author":"MS Roberts","year":"2017","unstructured":"Roberts MS, Mohammed Y, Pastore MN, Namjoshi S, Yousef S, Alinaghi A, et al. Topical and cutaneous delivery using nanosystems. J Control Release Netherlands. 2017;247:86\u2013105.","journal-title":"J Control Release Netherlands"},{"key":"896_CR82","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/jid.2012.461","volume":"133","author":"J Brewer","year":"2013","unstructured":"Brewer J, Bloksgaard M, Kubiak J, Sorensen JA, Bagatolli LA. Spatially resolved two-color diffusion measurements in human skin applied to transdermal liposome penetration. J Invest Dermatol United States. 2013;133:1260\u20138.","journal-title":"J Invest Dermatol United States"},{"key":"896_CR83","doi-asserted-by":"crossref","unstructured":"Dreier J, S\u00f8rensen JA, Brewer JR. Superresolution and fluorescence dynamics evidence reveal that intact liposomes do not cross the human skin barrier. PLoS One. Public Library of Science; 2016;11:e0146514.","DOI":"10.1371\/journal.pone.0146514"},{"key":"896_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0939-6411(03)00021-3","volume":"55","author":"DD Verma","year":"2003","unstructured":"Verma DD, Verma S, Blume G, Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm. 2003;55:271\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"896_CR85","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev Netherlands. 2004;56:603\u201318.","journal-title":"Adv Drug Deliv Rev Netherlands"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00896-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00896-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00896-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T15:07:47Z","timestamp":1667056067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00896-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00896-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"5 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors have consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}